Chronic epiphora secondary to ocular meibomianitis

Xiao Ping Ma, John Ng

Research output: Contribution to journalArticle

Abstract

AIM: To investigate the relationship between chronic epiphora and meibomianitis, and to explore the efficacy of the meibomianitis treatment to improve chronic tearing. METHODS: One thousand chronic epiphora patients chart review in Casey eye institute during 2000-2009. Review of 206 (20.6%) chronic epiphora patients who underwent slit lamp examination were diagnosed meibomianitis. Diagnostic criteria were meibomian gland dysfunction, blepharitis, lid margin telangiectasia and hyperaemia punctuate superficial keratopathy. Treatment included maintenance of lid hygene, use of artificial tears, systemic and topical antibiotics, warm and moist compresses, topical corticosteroid and diet supplementation with Omega-3 fatty acids. RESULTS: Among all the patients, 206(20.6%) meibomianitis patients (average age 65.8 years, average tearing time 2.78 years). White patients 196 (95%); female 106 (51.5%), male 100 (48.5%). Average follow up time was 5.07mo. 152 (73.79%) of 206 meibomianitis patients with tearing got improved through treatments. 43 (20.87%) patients were treated without improvement. The failure reasons cannot be found in 14 (6.81%) of 43 patients. 29 (14.08%) of 43 pateients with chronic epiphora do not want to treat for a long time, which cause the treatment failure. 11 (5.34%) of 206 meibomianitis patients lost to follow up. CONCLUSION: The patients who presented to our office for the tearing 20.6% had meibomianitis. Through treatment of meibomianitis, tearing improved 73.78%. So patients with meibomianitis should treat it actively. Some tearing patients after the surgery still tearing should pay attention to treat meibomianitis.

Original languageEnglish (US)
Pages (from-to)386-389
Number of pages4
JournalInternational Eye Science
Volume14
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Lacrimal Apparatus Diseases
Blepharitis
Meibomian Glands
Telangiectasis
Lost to Follow-Up
Hyperemia
Omega-3 Fatty Acids
Treatment Failure

Keywords

  • Blepharitis
  • Epiphora
  • Meibomianitis
  • Ocular surface
  • Tearing

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Chronic epiphora secondary to ocular meibomianitis. / Ma, Xiao Ping; Ng, John.

In: International Eye Science, Vol. 14, No. 3, 2014, p. 386-389.

Research output: Contribution to journalArticle

Ma, Xiao Ping ; Ng, John. / Chronic epiphora secondary to ocular meibomianitis. In: International Eye Science. 2014 ; Vol. 14, No. 3. pp. 386-389.
@article{ba2a18f91c274aeea48fe54da79d29e9,
title = "Chronic epiphora secondary to ocular meibomianitis",
abstract = "AIM: To investigate the relationship between chronic epiphora and meibomianitis, and to explore the efficacy of the meibomianitis treatment to improve chronic tearing. METHODS: One thousand chronic epiphora patients chart review in Casey eye institute during 2000-2009. Review of 206 (20.6{\%}) chronic epiphora patients who underwent slit lamp examination were diagnosed meibomianitis. Diagnostic criteria were meibomian gland dysfunction, blepharitis, lid margin telangiectasia and hyperaemia punctuate superficial keratopathy. Treatment included maintenance of lid hygene, use of artificial tears, systemic and topical antibiotics, warm and moist compresses, topical corticosteroid and diet supplementation with Omega-3 fatty acids. RESULTS: Among all the patients, 206(20.6{\%}) meibomianitis patients (average age 65.8 years, average tearing time 2.78 years). White patients 196 (95{\%}); female 106 (51.5{\%}), male 100 (48.5{\%}). Average follow up time was 5.07mo. 152 (73.79{\%}) of 206 meibomianitis patients with tearing got improved through treatments. 43 (20.87{\%}) patients were treated without improvement. The failure reasons cannot be found in 14 (6.81{\%}) of 43 patients. 29 (14.08{\%}) of 43 pateients with chronic epiphora do not want to treat for a long time, which cause the treatment failure. 11 (5.34{\%}) of 206 meibomianitis patients lost to follow up. CONCLUSION: The patients who presented to our office for the tearing 20.6{\%} had meibomianitis. Through treatment of meibomianitis, tearing improved 73.78{\%}. So patients with meibomianitis should treat it actively. Some tearing patients after the surgery still tearing should pay attention to treat meibomianitis.",
keywords = "Blepharitis, Epiphora, Meibomianitis, Ocular surface, Tearing",
author = "Ma, {Xiao Ping} and John Ng",
year = "2014",
doi = "10.3980/j.issn.1672-5123.2014.03.02",
language = "English (US)",
volume = "14",
pages = "386--389",
journal = "International Eye Science",
issn = "1672-5123",
publisher = "Press of International Journal of Ophthalmology",
number = "3",

}

TY - JOUR

T1 - Chronic epiphora secondary to ocular meibomianitis

AU - Ma, Xiao Ping

AU - Ng, John

PY - 2014

Y1 - 2014

N2 - AIM: To investigate the relationship between chronic epiphora and meibomianitis, and to explore the efficacy of the meibomianitis treatment to improve chronic tearing. METHODS: One thousand chronic epiphora patients chart review in Casey eye institute during 2000-2009. Review of 206 (20.6%) chronic epiphora patients who underwent slit lamp examination were diagnosed meibomianitis. Diagnostic criteria were meibomian gland dysfunction, blepharitis, lid margin telangiectasia and hyperaemia punctuate superficial keratopathy. Treatment included maintenance of lid hygene, use of artificial tears, systemic and topical antibiotics, warm and moist compresses, topical corticosteroid and diet supplementation with Omega-3 fatty acids. RESULTS: Among all the patients, 206(20.6%) meibomianitis patients (average age 65.8 years, average tearing time 2.78 years). White patients 196 (95%); female 106 (51.5%), male 100 (48.5%). Average follow up time was 5.07mo. 152 (73.79%) of 206 meibomianitis patients with tearing got improved through treatments. 43 (20.87%) patients were treated without improvement. The failure reasons cannot be found in 14 (6.81%) of 43 patients. 29 (14.08%) of 43 pateients with chronic epiphora do not want to treat for a long time, which cause the treatment failure. 11 (5.34%) of 206 meibomianitis patients lost to follow up. CONCLUSION: The patients who presented to our office for the tearing 20.6% had meibomianitis. Through treatment of meibomianitis, tearing improved 73.78%. So patients with meibomianitis should treat it actively. Some tearing patients after the surgery still tearing should pay attention to treat meibomianitis.

AB - AIM: To investigate the relationship between chronic epiphora and meibomianitis, and to explore the efficacy of the meibomianitis treatment to improve chronic tearing. METHODS: One thousand chronic epiphora patients chart review in Casey eye institute during 2000-2009. Review of 206 (20.6%) chronic epiphora patients who underwent slit lamp examination were diagnosed meibomianitis. Diagnostic criteria were meibomian gland dysfunction, blepharitis, lid margin telangiectasia and hyperaemia punctuate superficial keratopathy. Treatment included maintenance of lid hygene, use of artificial tears, systemic and topical antibiotics, warm and moist compresses, topical corticosteroid and diet supplementation with Omega-3 fatty acids. RESULTS: Among all the patients, 206(20.6%) meibomianitis patients (average age 65.8 years, average tearing time 2.78 years). White patients 196 (95%); female 106 (51.5%), male 100 (48.5%). Average follow up time was 5.07mo. 152 (73.79%) of 206 meibomianitis patients with tearing got improved through treatments. 43 (20.87%) patients were treated without improvement. The failure reasons cannot be found in 14 (6.81%) of 43 patients. 29 (14.08%) of 43 pateients with chronic epiphora do not want to treat for a long time, which cause the treatment failure. 11 (5.34%) of 206 meibomianitis patients lost to follow up. CONCLUSION: The patients who presented to our office for the tearing 20.6% had meibomianitis. Through treatment of meibomianitis, tearing improved 73.78%. So patients with meibomianitis should treat it actively. Some tearing patients after the surgery still tearing should pay attention to treat meibomianitis.

KW - Blepharitis

KW - Epiphora

KW - Meibomianitis

KW - Ocular surface

KW - Tearing

UR - http://www.scopus.com/inward/record.url?scp=84896264744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896264744&partnerID=8YFLogxK

U2 - 10.3980/j.issn.1672-5123.2014.03.02

DO - 10.3980/j.issn.1672-5123.2014.03.02

M3 - Article

VL - 14

SP - 386

EP - 389

JO - International Eye Science

JF - International Eye Science

SN - 1672-5123

IS - 3

ER -